National Research Corporation (NRC)
NASDAQ: NRC · IEX Real-Time Price · USD
34.27
+0.03 (0.09%)
At close: Apr 24, 2024, 4:00 PM
35.03
+0.76 (2.22%)
After-hours: Apr 24, 2024, 6:40 PM EDT

Company Description

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience.

Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.

The company also offers marketing solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools.

In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools.

Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership.

National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

National Research Corporation
National Research logo
Country United States
Founded 1981
Industry Health Information Services
Sector Healthcare
Employees 435
CEO Michael D. Hays

Contact Details

Address:
1245 Q Street
Lincoln, Nebraska 68508
United States
Phone (402) 475-2525
Website nrchealth.com

Stock Details

Ticker Symbol NRC
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000070487
CUSIP Number 637372202
ISIN Number US6373722023
Employer ID 47-0634000
SIC Code 8731

Key Executives

Name Position
Michael D. Hays Founder, Chief Executive Officer, President and Director
Helen L. Hrdy Chief Customer Officer
Linda Stacy Principal Accounting Officer
Christophe Louvion Chief Product and Technology Officer
Andy Monnich Chief Corporate Development Officer
Jon Boumstein Chief Delivery Officer
Dr. Gregory Makoul M.S., Ph.D. Chief Transformation Officer
Jason Hahn Chief Revenue Officer
Megan Charko Senior Manager of Content Marketing

Latest SEC Filings

Date Type Title
Apr 11, 2024 DEF 14A Other definitive proxy statements
Mar 8, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Mar 5, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Feb 27, 2024 10-K Annual Report
Feb 13, 2024 8-K Current Report
Feb 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Jan 17, 2024 8-K Current Report
Jan 4, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Jan 2, 2024 8-K Current Report
Nov 15, 2023 144 Filing